Abstract
The purpose of this paper was to understand, based on a theoretical discussion, why Argentina used STI policy instruments to strengthen the strategic health sector, especially that of Public Production of Medicines (PPM). To this end, first, a brief introduction to the problem was made and the research question that guided the analysis was presented. Next, the political motives for innovation intervention were explored, with special emphasis on the relevance of the policy of non-neutral intervention. Thirdly, the notion of policy instrument applied to the fields of science, technology and innovation (STI) was defined, introducing its typology, to finally identify its impact on PPM in order to obtain indications of the motives that would justify the definition of STI policy instruments aimed at strengthening an area considered strategic at the national level.
Publisher
Salud, Ciencia y Tecnologia
Reference24 articles.
1. Lettieri, M., Repetto,C. y Roca, A. (2022). La articulación entre las políticas de I+D, salud y productivas: ANLAP y la experiencia del Kit Serocovid Federal. En Congreso Argentino de Estudios Sociales de la Ciencia y la Tecnología (CAESCYT 2022).
2. Zubeldía, L., & Hurtado, D. (2019). Política tecnológica e industrial en contexto semiperiférico: la producción pública de medicamentos en Argentina (2007- 2015). Revista Perspectivas de Políticas Públicas, 8(16), 299-327.
3. Tobar, F. (2002) “Acceso a los medicamentos en Argentina: Diagnóstico y Alternativas”. Boletín Fármacos, 5(4).
4. Foray, D. (2019). On sector-non-neutral innovation policy: towards new design principles. Journal of Evolutionary Economics, 29(5), 1379-1397.
5. Vázquez, R. D. (2018). La política tecnológica orientada por misiones y sus spillovers: un análisis empírico de las misiones dirigidas a defensa y salud humana para 1995- 2014.